Retinitis pigmentosa (RP)
Clinical trials for Retinitis pigmentosa (RP) explained in plain language.
Never miss a new study
Get alerted when new Retinitis pigmentosa (RP) trials appear
Sign up with your email to follow new studies for Retinitis pigmentosa (RP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an eye injection slow a genetic cause of blindness?
Disease control Not yet recruitingThis trial tests the long-term safety of an experimental medicine called ultevursen, given as an injection into the eye, for people with retinitis pigmentosa caused by mutations in a gene called USH2A. The study enrolls about 81 adults and children who completed a previous 24-mon…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a statin nanoparticle save sight in retinitis pigmentosa?
Disease control Not yet recruitingThis phase 1 trial tests whether an intravenous nanoparticle formulation of pitavastatin, called ULREA-PVS-NP, is safe in adults with retinitis pigmentosa, a rare inherited disease that causes progressive vision loss. The study aims to see if the treatment can reduce retinal infl…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase 1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can an antioxidant pill slow blindness in usher syndrome?
Disease control Not yet recruitingThis phase 3 trial tests whether an experimental drug called NPI-001 can slow the loss of light-sensing cells in the eyes of adults with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 participants take either NPI-001 or a placebo twice dail…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase 3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug aims to preserve sight in rare genetic blindness
Disease control Not yet recruitingThis phase 3 trial tests whether NPI-001, taken twice daily for 24 months, can slow the loss of light-sensing cells in the eyes of adults with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 participants will receive either the drug or a pla…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase 3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Gene therapy injection aims to save sight in rare eye disease
Disease control Not yet recruitingThis early-stage trial tests a single injection of ZM-02, a gene therapy, in 21 people aged 6 to 60 with advanced retinitis pigmentosa, a genetic condition that causes progressive vision loss. Participants are randomly assigned to receive either a low or high dose of ZM-02 or a s…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase 1/2 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Gene therapy injection aims to slow vision loss in rare eye disease
Disease control Not yet recruitingThis early-stage trial tests a single injection of a gene therapy drug called UGX202 in 6 adults with advanced retinitis pigmentosa, a genetic condition that causes vision loss. The main goal is to check if the treatment is safe and tolerable over 52 weeks. Researchers will also …
Matched conditions: RETINITIS PIGMENTOSA (RP)
Early phase 1 • Sponsor: Suzhou UgeneX Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Matched conditions: RETINITIS PIGMENTOSA (RP)
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Scientists track eye disease patterns to speed future cures
Knowledge-focused Not yet recruitingThis study looks back at medical records of 200 people with inherited retinal diseases, like retinitis pigmentosa and Stargardt disease. Researchers will analyze vision tests and eye scans to see how these diseases progress and how genetics affect symptoms. The goal is to find be…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC